| Literature DB >> 19856677 |
Luigi De Cicco1, Andrea Vavassori, Federica Cattani, Barbara A Jereczek-Fossa, Roberto Orecchia.
Abstract
No standard treatment exists for locally relapsed prostate cancer after primary external beam radiotherapy with no evidence of distant metastases. Radical prostatectomy, brachytherapy, cryotherapy and high-intensity focused ultrasound are currently used as local salvage treatments. Data on the safety and effectiveness of high dose rate (HDR) brachytherapy in this scenario are limited. We report on a patient who has no evidence of disease and no late urinary or gastrointestinal toxicity 33 months after receiving HDR treatment for recurrent prostate cancer.Entities:
Mesh:
Year: 2009 PMID: 19856677 DOI: 10.1177/030089160909500429
Source DB: PubMed Journal: Tumori ISSN: 0300-8916